196 Participants Needed

Bupivacaine vs. Liposomal Bupivacaine for Postoperative Pain

AT
RJ
Overseen ByRoberta Johnson
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Patients will be randomized the day of surgery upon presentation to the operating room to either a treatment group (PECSII/SAP blocks with bupivacaine HCl plus liposomal bupivacaine) or a control group (PECSII/SAP blocks with bupivacaine HCl plus preservative free normal saline) using secure web-based randomization. Assignments will be based on computer-generated code. Clinicians will not be blinded to the intervention, but all outcomes will be assessed by research personnel who are blinded to the group assignment.

Research Team

AT

Alparslan Turan, MD

Principal Investigator

The Cleveland Clinic

Eligibility Criteria

This trial is for adults aged 18-85 undergoing certain thoracic surgeries like VATS or robotic pulmonary resection. Candidates must not be on high doses of opioids, have active liver disease, pacemakers or implants near the surgery site, weigh under 50 kg, be pregnant or breastfeeding, require emergency surgery from ICU, have severe kidney issues, infections, uncontrolled psychiatric disorders or known allergies to local anesthetics.

Inclusion Criteria

I have had lung surgery using small cuts or robotic assistance.

Exclusion Criteria

Previous participation in this study
Poorly controlled psychiatric disorders
My kidney function is severely reduced.
See 13 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 day
1 visit (in-person)

Treatment

Participants receive PECSII and serratus anterior plane blocks with either bupivacaine HCl plus liposomal bupivacaine or bupivacaine HCl plus saline

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of analgesia score

3 days
Postoperative day 3 assessment

Treatment Details

Interventions

  • Bupivacaine
  • Liposomal Bupivacaine
Trial Overview The study compares pain management in thoracic surgery patients using two types of blocks: one with bupivacaine HCl and liposomal bupivacaine (treatment group) versus bupivacaine HCl with saline (control group). Participants are randomly assigned to groups and outcome assessments are done by researchers unaware of which group each patient is in.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Bupi HCl plus liposomal bupiExperimental Treatment1 Intervention
PECSII/SAP blocks with bupivacaine HCl plus liposomal bupivacaine
Group II: Bupi HCl plus salineActive Control1 Intervention
PECSII/SAP blocks with bupivacaine HCl plus preservative free normal saline

Bupivacaine is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Marcaine for:
  • Local anesthesia for surgery
  • Acute pain management
  • Spinal anesthesia
🇪🇺
Approved in European Union as Marcaine for:
  • Local anesthesia for surgery
  • Acute pain management
  • Spinal anesthesia
🇨🇦
Approved in Canada as Sensorcaine for:
  • Local anesthesia for surgery
  • Acute pain management
  • Spinal anesthesia

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security